Recalls / Class II
Class IID-0259-2026
Product
Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10.
- Brand name
- Levothyroxine Sodium
- Generic name
- Levothyroxine Sodium
- Active ingredient
- Levothyroxine Sodium
- Route
- Oral
- NDCs
- 47781-640, 47781-643, 47781-646, 47781-649, 47781-651, 47781-654, 47781-657, 47781-659, 47781-662, 47781-665 +2 more
- FDA application
- NDA021116
- Affected lot / code info
- Lot # MHA21825, Exp Date: December 31, 2027
Why it was recalled
Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
Recalling firm
- Firm
- Alvogen, Inc
- Manufacturer
- Alvogen, Inc.
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 44 Whippany Rd Ste 300, Morristown, New Jersey 07960-4558
Distribution
- Distribution pattern
- US Nationwide.
Timeline
- Recall initiated
- 2025-12-31
- FDA classified
- 2026-01-14
- Posted by FDA
- 2026-01-21
- Status
- Ongoing
Source: openFDA Drug Enforcement endpoint. Recall record D-0259-2026. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.